Manage through clinical trial uncertainties

From monitoring protocol and patient eligibility criteria changes to evaluating the feasibility of alternate sites and tracking peers’ activities to inform your own strategy, COVID-19 is disrupting clinical development and making it more challenging than ever to understand the trial landscape.

Cortellis Clinical Trials Intelligence makes it easy to track and access reputable information sources that have been expertly curated from literature, trial registries and company press releases – all in one intuitive platform. In this webinar (one of four in our “Managing through today’s (even more) dynamic R&D environment” series), our experts will demonstrate actionable tips and tricks to make your efforts more efficient – and help keep clinical operations on track.

Fill out the form at the right to learn how to:

• Spot whether peers have temporarily paused, halted or delayed trials or patient enrollment – and find out when they start up again
• Monitor if and how protocols or patient eligibility criteria are being modified
• Evaluate if it’s feasible to find other experienced site alternatives